Literature DB >> 25546767

Subclinical infection and dosing in primary immunodeficiencies.

S Jolles1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25546767      PMCID： PMC4285496          DOI： 10.1111/cei.12516

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  16 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

2.  Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection.

Authors:  Vincent R Bonagura; Robert Marchlewski; Amanda Cox; David W Rosenthal
Journal:  J Allergy Clin Immunol       Date:  2008-07       Impact factor: 10.793

3.  Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

Authors:  Mary Lucas; Martin Lee; Jenny Lortan; Eduardo Lopez-Granados; Siraj Misbah; Helen Chapel
Journal:  J Allergy Clin Immunol       Date:  2010-05-14       Impact factor: 10.793

4.  Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies.

Authors:  Yan Chen; Rob G Stirling; Eldho Paul; Fiona Hore-Lacy; Bruce R Thompson; Jo A Douglass
Journal:  J Allergy Clin Immunol       Date:  2011-05-04       Impact factor: 10.793

5.  Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies.

Authors:  Jordan S Orange; William J Grossman; Roberta J Navickis; Mahlon M Wilkes
Journal:  Clin Immunol       Date:  2010-08-01       Impact factor: 3.969

6.  Morbidity and mortality in common variable immune deficiency over 4 decades.

Authors:  Elena S Resnick; Erin L Moshier; James H Godbold; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2011-12-16       Impact factor: 22.113

7.  Viruses and bacteria in bronchial samples from patients with primary hypogammaglobulinemia.

Authors:  L Kainulainen; J Nikoskelainen; T Vuorinen; K Tevola; K Liippo; O Ruuskanen
Journal:  Am J Respir Crit Care Med       Date:  1999-04       Impact factor: 21.405

8.  Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity.

Authors:  Goffredo Serra; Cinzia Milito; Milica Mitrevski; Guido Granata; Helene Martini; Anna Maria Pesce; Ifigenia Sfika; Livia Bonanni; Carlo Catalano; Francesco Fraioli; Isabella Quinti
Journal:  Chest       Date:  2011-05-26       Impact factor: 9.410

9.  Common variable immunodeficiency disorders: division into distinct clinical phenotypes.

Authors:  Helen Chapel; Mary Lucas; Martin Lee; Janne Bjorkander; David Webster; Bodo Grimbacher; Claire Fieschi; Vojtech Thon; Mohammad R Abedi; Lennart Hammarstrom
Journal:  Blood       Date:  2008-03-04       Impact factor: 22.113

10.  Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia.

Authors:  Leena Kainulainen; Tytti Vuorinen; Kaisu Rantakokko-Jalava; Riikka Osterback; Olli Ruuskanen
Journal:  J Allergy Clin Immunol       Date:  2010-06-11       Impact factor: 10.793
View more
  7 in total

Review 1.  When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.

Authors:  S Jolles; H Chapel; J Litzman
Journal:  Clin Exp Immunol       Date:  2017-01-30       Impact factor: 4.330

2.  Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group.

Authors:  S Jolles; S Sánchez-Ramón; I Quinti; P Soler-Palacín; C Agostini; B Florkin; L-J Couderc; N Brodszki; A Jones; H Longhurst; K Warnatz; F Haerynck; A Matucci; E de Vries
Journal:  Clin Exp Immunol       Date:  2017-08-25       Impact factor: 4.330

Review 3.  Primary immunodeficiency diseases in lung disease: warning signs, diagnosis and management.

Authors:  Pere Soler-Palacín; Javier de Gracia; Luis Ignacio González-Granado; Carlos Martín; Carlos Rodríguez-Gallego; Silvia Sánchez-Ramón
Journal:  Respir Res       Date:  2018-11-12

4.  The role of respiratory viruses in children with humoral immunodeficiency on immunoglobulin replacement therapy.

Authors:  Marta Benavides-Nieto; Ana Méndez-Echevarría; Teresa Del Rosal; María Luz García-García; Inmaculada Casas; Francisco Pozo; Olga de la Serna; Eduardo Lopez-Granados; Rebeca Rodriguez-Pena; Cristina Calvo
Journal:  Pediatr Pulmonol       Date:  2018-12-21

Review 5.  RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.

Authors:  Richard L Wasserman; Benjamin N Greener; James Mond
Journal:  Expert Rev Clin Immunol       Date:  2017-10-16       Impact factor: 4.473

Review 6.  Beyond monogenetic rare variants: tackling the low rate of genetic diagnoses in predominantly antibody deficiency.

Authors:  Emily S J Edwards; Julian J Bosco; Samar Ojaimi; Robyn E O'Hehir; Menno C van Zelm
Journal:  Cell Mol Immunol       Date:  2020-08-17       Impact factor: 11.530

Review 7.  The Lung in Primary Immunodeficiencies: New Concepts in Infection and Inflammation.

Authors:  Ulrich Baumann; John M Routes; Pere Soler-Palacín; Stephen Jolles
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.